Neulasta (Pegfilgrastim): A once-per-cycle option for the management of chemotherapy-induced neutropenia

被引：34

作者：

Biganzoli, L ^{[1
]}

Untch, M

Skacel, T

Pico, JL

机构：

[1] Prato Hosp, Dept Oncol, Sandro Pitigliani Med Oncol Unit, Prato, Italy

[2] Univ Munich, Munich, Germany

[3] Amgen GmbH Europe, Luzern, Switzerland

[4] Amgen AG Europe, Neuilly Sur Seine, France

来源：

SEMINARS IN ONCOLOGY | 2004年 / 31卷 / 03期

关键词：

D O I：

10.1053/j.seminoncol.2004.04.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：27 / 34

页数：8

共 42 条

[11] A European perspective on haematopoietic growth factors in haemato-oncology: Report of an expert meeting of the EORTC [J].

Croockewit, AJ ;

Bronchud, MH ;

Aapro, MS ;

Bargetzi, MJ ;

Crown, J ;

Gratwohl, A ;

Lange, W ;

Ludwig, H ;

Martinelli, G ;

Mertelsmann, R ;

Nuessler, V ;

Willemze, R ;

DeWitte, TJM ;

Zittoun, R ;

Zwierzina, H .

EUROPEAN JOURNAL OF CANCER, 1997, 33 (11) :1732-1746

[12] Colony-stimulating factors for the management of neutropenia in cancer patients [J].

Dale, DC .

DRUGS, 2002, 62 (Suppl 1) :1-15

[13]

deGraaf H, 1996, ONCOLOGY, V53, P289

[14]

DELGADO C, 1992, CRIT REV THER DRUG, V9, P249

[15]

Freifeld Alison G., 1997, P2659

[16] Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma:: Results of a multivariate analysis [J].

Gómez, H ;

Hidalgo, M ;

Casanova, L ;

Colomer, R ;

Pen, DLK ;

Otero, J ;

Rodríguez, W ;

Carracedo, C ;

Cortés-Funes, H ;

Vallejos, C .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) :2065-2069

[17] A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy [J].

Green, MD ;

Koelbl, H ;

Baselga, J ;

Galid, A ;

Guillem, V ;

Gascon, P ;

Siena, S ;

Lalisang, RI ;

Samonigg, H ;

Clemens, MR ;

Zani, V ;

Liang, BC ;

Renwick, J ;

Piccart, MJ .

ANNALS OF ONCOLOGY, 2003, 14 (01) :29-35

[18]

Greil R, 2001, ANN ONCOL, V12, P1219

[19] Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer [J].

Holmes, FA ;

Jones, SE ;

O'Shaughnessy, J ;

Vukelja, S ;

George, T ;

Savin, M ;

Richards, D ;

Glaspy, J ;

Mesa, L ;

Cohen, G ;

Dhami, M ;

Budman, DR ;

Hackett, J ;

Brassard, M ;

Yang, BB ;

Liang, BC .

ANNALS OF ONCOLOGY, 2002, 13 (06) :903-909

[20] Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer [J].

Holmes, FA ;

O'Shaughnessy, JA ;

Vukelja, S ;

Jones, SE ;

Shogan, J ;

Savin, M ;

Glaspy, J ;

Moore, M ;

Meza, L ;

Wiznitzer, I ;

Neumann, TA ;

Hill, LR ;

Liang, BC .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :727-731

← 1 2 3 4 5 →